Many natural compounds that act on the human body provide active ingredients for medicines or clues for developing them, and ...

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

NVIDIA and Lilly bring together a world-leading, multidisciplinary team of scientists, AI researchers and engineers to ...

Millions of people live with atrial fibrillation, a racing, uneven heartbeat that can leave you exhausted and scared. Yet it ...

Insilico Medicine, an artificial intelligence-driven drug discovery company backed by Qiming Venture Partners, made its debut ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Opportunities in RNA Targeting Small Molecule Drug Discovery are driven by advances in RNA biology, structural analysis, and ...

Cambridge, Massachusetts, January 14, 2025 - Insilico Medicine (“Insilico”, HKEX:03696), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced the ...

Jan 6 () - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that ​uses artificial intelligence ...

Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...

Biopharmaceutical artificial intelligence startup Owkin Inc. said today it’s making a series of autonomous agents focused on ...

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...